Evidence map›Paper›PMID 40607749›Full record

ArticleThe Journal of dermatology2025

The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.

Sei-Ichiro Motegi, Mona Uchida-Yamada, Yoshihito Shima, Taku Shimada, Haruka Ishii, Yoshito Ohya, Yasumasa Kanai

Abstract read
In one paragraph

Article in The Journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sei-Ichiro MotegiDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.ORCID https://orcid.org/0000-0001-8286-0669
Mona Uchida-YamadaMedical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.ORCID https://orcid.org/0000-0002-5781-9485
Yoshihito ShimaLaboratory of Thermo-Therapeutics for Vascular Dysfunction, Osaka University Graduate School of Medicine, Suita, Japan.ORCID https://orcid.org/0000-0002-2523-2938
Taku ShimadaMedical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Haruka IshiiMedical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Yoshito OhyaMedical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Yasumasa KanaiMedical Affairs, Kyowa Kirin Co., Ltd., Tokyo, Japan.ORCID https://orcid.org/0009-0005-0300-4917

Funding

Kyowa Kirin Pharmaceutical Development
6 · The paper itself

Abstract

We investigated pain prevalence and severity in systemic sclerosis (SSc) and patient-physician perceptions. This was an internet-based survey that compared perceptions of pain type, location, severity, associated factors between patients with SSc and physicians, and pain treatment prescription patterns in Japan in March 2023. Data from 301 patients and 129 physicians revealed that 96.0% of patients experienced pain compared with 43.4% estimated by physicians. The median (interquartile range) Short-form McGill Pain Questionnaire (SF-MPQ-2) pain score was 47.0 (14.0-88.0). Continuous pain had the highest score (16.0 [3.0-27.0]), followed by neuropathic pain (14.0 [5.0-25.0]), intermittent pain (11.0 [1.0-25.0]), and affective descriptors (5.0 [1.0-14.0]). Pain at joints, fingertips, Raynaud's phenomenon (RP), and skin tightening were most prevalent across multiple pain types. Pain at fingertips and RP-affected locations were more common in limited cutaneous SSc (lcSSc) than in diffuse cutaneous SSc (dcSSc), and skin tightening was more common in dcSSc. Patients with dcSSc had significantly more severe pain than patients with lcSSc. Patients with nausea, insomnia, or diarrhea showed higher SF-MPQ-2 scores. Of the 129 physicians surveyed, 58.9% prescribed painkillers, 48.8% suggested self-care, 42.6% treated skin symptoms, and 16.3% referred patients to pain clinics for further management. Compared to the percentage of patients having pain in each location, physicians tend to be less aware of pain in the muscles, head, and abdomen. Most patients with SSc experience pain, which physicians tended to underestimate. Physicians' awareness of patients' experiences should be improved to provide adequate treatment for pain in SSc. Trial Registration: UMIN000050368.

Indexed as

NeuralgiaPainScleroderma, SystemicAdultAgedFemaleHumansJapanMaleMiddle AgedPain ManagementPain MeasurementPrevalenceRaynaud DiseaseSeverity of Illness IndexSurveys and Questionnairesgap analysisphysiciansquestionnaireSF‐MPQ‐2systemic sclerosis

Identifiers

PMID40607749
PMCPMC12411825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.